Literature DB >> 16158212

Plasma fibrinogen level: an independent risk factor for long-term survival in Chinese patients with peripheral artery disease?

Bernice L Y Cheuk1, Grace C Y Cheung, Silvana S F Lau, Stephen W K Cheng.   

Abstract

Fibrinogen, an inflammatory marker as well as a fundamental part of the coagulation cascade, is suggested to play a significant role in the pathogenesis of atherosclerosis and complications of atherothrombotic diseases. The aim of this study was to determine if plasma fibrinogen is an independent risk factor for long-term survival in patients with peripheral artery disease (PAD). Altogether, 139 Chinese patients (88 men, 51 women) with PAD were consecutively recruited for the study. Atherothrombotic risk factors and fibrinogen levels were determined at presentation, and all patients were followed up for mortality prospectively. The mean follow-up was 6 years. All variables were first correlated with survival rates using Kaplan-Meier analysis and compared by means of the log-rank test. Significant risk factors were identified, and multivariate Cox regression analysis was used to evaluate the independent contribution of the fibrinogen level to the risk of mortality. During follow-up, 95 patients (68.3%) died. The overall survival rate was 77.7% at 3 years, 56.8% at 5 years, and 31.2% at 10 years (standard errors 0.05, 0.06, and 0.07, respectively). All-cause mortality rate increased with an elevated fibrinogen level. Eighty percent of patients with a fibrinogen level > 3.4 g/L had a survival time of less than 3 years (p = 0.002). This relation was also demonstrated within patients with critical ischemia. The plasma fibrinogen level was thus identified as an independent risk factor for mortality in PAD patients after adjusting for confounding factors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16158212     DOI: 10.1007/s00268-005-7802-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.282


  30 in total

1.  Recommended standards for reports dealing with lower extremity ischemia: revised version.

Authors:  R B Rutherford; J D Baker; C Ernst; K W Johnston; J M Porter; S Ahn; D N Jones
Journal:  J Vasc Surg       Date:  1997-09       Impact factor: 4.268

2.  Cross-sectional association of soluble thrombomodulin with mild peripheral artery disease; the ARIC study. Atherosclerosis Risk in Communities.

Authors:  V Salomaa; C Matei; N Aleksic; L Sansores-Garcia; A R Folsom; H Juneja; E Park; K K Wu
Journal:  Atherosclerosis       Date:  2001-08       Impact factor: 5.162

3.  Influence of platelet size on outcome after myocardial infarction.

Authors:  J F Martin; P M Bath; M L Burr
Journal:  Lancet       Date:  1991-12-07       Impact factor: 79.321

4.  Fasting total plasma homocysteine and atherosclerotic peripheral vascular disease.

Authors:  S W Cheng; A C Ting; J Wong
Journal:  Ann Vasc Surg       Date:  1997-05       Impact factor: 1.466

5.  Fibrinogen, other cardiovascular risk factors and diabetes mellitus in Hong Kong: a community with high prevalence of Type 2 diabetes mellitus and impaired glucose tolerance.

Authors:  T H Lam; L J Liu; E D Janus; K S Lam; A J Hedley
Journal:  Diabet Med       Date:  2000-11       Impact factor: 4.359

6.  Fibrinogen genotypes (alpha and beta) are associated with plasma fibrinogen levels in Chinese.

Authors:  Y Liu; N Saha; C K Heng; S Hong; P S Low
Journal:  J Med Genet       Date:  2001-09       Impact factor: 6.318

Review 7.  Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence.

Authors:  J W Eikelboom; E Lonn; J Genest; G Hankey; S Yusuf
Journal:  Ann Intern Med       Date:  1999-09-07       Impact factor: 25.391

Review 8.  Atherosclerosis.

Authors:  A J Lusis
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

9.  [The whole blood and plasma viscosity changes in course of acute myocardial infarction].

Authors:  Bolesław Turczyński; Ludmiła Słowińska; Stanisław Szczesny; Marek Baschton; Anita Bartosik-Baschton; Jacek Szyguła; Jan Wodniecki; Janusz Spyra
Journal:  Pol Arch Med Wewn       Date:  2002-10

10.  Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha.

Authors:  T Bombeli; B R Schwartz; J M Harlan
Journal:  J Exp Med       Date:  1998-02-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.